Showing results (2871-2880 of 3,662) with videos related to
Sort By:
Pageof 367
Breast (Edinburgh, Scotland)|December 20, 2021
Unmet challenges in systemic therapy for early stage breast cancerHarold J BursteinBreast (Edinburgh, Scotland)|December 20, 2021
Surgery and prophylactic surgery in hereditary breast cancerMonica MorrowBreast (Edinburgh, Scotland)|November 25, 2021
Breast magnetic resonance imaging as a problem solving tool in women recalled at biennial screening mammography: A population-based study in the NetherlandsJessie Jj Gommers, Adri C Voogd, Mireille Jm Broeders, et al.Breast (Edinburgh, Scotland)|December 24, 2021
De-escalating axillary surgery in early-stage breast cancerEliza H Hersh, Tari A KingBreast (Edinburgh, Scotland)|March 5, 2021
Tired of feeling tired - The role of circulating inflammatory biomarkers and long-term cancer related fatigue in breast cancer survivorsT Maurer, S Jaskulski, S Behrens, et al.Breast (Edinburgh, Scotland)|November 4, 2021
Palbociclib in combination with aromatase inhibitors in patients ≥ 75 years with oestrogen receptor-positive, human epidermal growth factor receptor 2 negative advanced breast cancer: A real-world multicentre UK studySalma El Badri, Bilal Tahir, Kirsty Balachandran, et al.Breast (Edinburgh, Scotland)|October 20, 2022
Neoadjuvant therapy in triple-negative breast cancer: A systematic review and network meta-analysisYing-Yi Lin, Hong-Fei Gao, Xin Yang, et al.Breast (Edinburgh, Scotland)|October 14, 2022
Imaging of lumpectomy surface with large field-of-view confocal laser scanning microscope for intraoperative margin assessment - POLARHIS studyMariana-Felicia Sandor, Beatrice Schwalbach, Viktoria Hofmann, et al.Breast (Edinburgh, Scotland)|October 24, 2022
Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancerMatti Aapro, Fatima Cardoso, Giuseppe Curigliano, et al.Breast (Edinburgh, Scotland)|October 11, 2022
Predictive and prognostic values of tumor infiltrating lymphocytes in breast cancers treated with neoadjuvant chemotherapy: A meta-analysisShiqi Li, Ying Zhang, Peigen Zhang, et al.Pageof 367